Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors

NCT02390843 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT02390843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02390843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study Using Simvastatin in Combination With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
September 22, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell sarcoma, ewings sarcoma, germ cell tumors, hepatoblastoma, neuroblastoma, non-rhabdomyosarcoma soft tissue sarcoma, osteosarcoma, renal cell carcinoma, retinoblastoma, rhabdoid tumor, rhabdomyosarcoma, wilms tumor